These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15351399)

  • 1. The anandamide membrane transporter. Structure-activity relationships of anandamide and oleoylethanolamine analogs with phenyl rings in the polar head group region.
    Di Marzo V; Ligresti A; Morera E; Nalli M; Ortar G
    Bioorg Med Chem; 2004 Oct; 12(19):5161-9. PubMed ID: 15351399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    J Med Chem; 2003 Apr; 46(8):1512-22. PubMed ID: 12672252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel tail-modified anandamide analogs.
    Yao F; Li C; Vadivel SK; Bowman AL; Makriyannis A
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5912-5. PubMed ID: 18723350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter.
    Chen N; Appell M; Berfield JL; Reith ME
    Eur J Pharmacol; 2003 Oct; 478(2-3):89-95. PubMed ID: 14575792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand.
    Khanolkar AD; Abadji V; Lin S; Hill WA; Taha G; Abouzid K; Meng Z; Fan P; Makriyannis A
    J Med Chem; 1996 Oct; 39(22):4515-9. PubMed ID: 8893848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
    J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.
    Ruiz-Llorente L; Ortega-Gutiérrez S; Viso A; Sánchez MG; Sánchez AM; Fernández C; Ramos JA; Hillard C; Lasunción MA; López-Rodríguez ML; Díaz-Laviada I
    Br J Pharmacol; 2004 Feb; 141(3):457-67. PubMed ID: 14718261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand.
    Khanolkar AD; Makriyannis A
    Life Sci; 1999; 65(6-7):607-16. PubMed ID: 10462061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
    Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
    J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity.
    Appendino G; Minassi A; Berton L; Moriello AS; Cascio MG; De Petrocellis L; Di Marzo V
    J Med Chem; 2006 Apr; 49(7):2333-8. PubMed ID: 16570929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anandamide transporter-mediated regulation of the micturition reflex in urethane-anesthetized rats.
    Honda M; Yoshimura N; Kawamoto B; Hikita K; Muraoka K; Shimizu S; Saito M; Chancellor MB; Takenaka A
    Int Urol Nephrol; 2016 Sep; 48(9):1407-12. PubMed ID: 27256398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rise and fall of anandamide: processes that control synthesis, degradation, and storage.
    Biringer RG
    Mol Cell Biochem; 2021 Jul; 476(7):2753-2775. PubMed ID: 33713246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter.
    Ligresti A; De Petrocellis L; Hernán Pérez de la Ossa D; Aberturas R; Cristino L; Moriello AS; Finizio A; Gil ME; Torres AI; Molpeceres J; Di Marzo V
    PLoS One; 2010 Apr; 5(4):e10239. PubMed ID: 20422025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
    Rockwell CE; Kaminski NE
    J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide receptor signal transduction.
    Goodfellow CE; Glass M
    Vitam Horm; 2009; 81():79-110. PubMed ID: 19647109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
    Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
    J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
    Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.